Latest News & Features
Big Pharma
UK patients could be more exposed to counterfeit medicines than EU patients in the event of a ‘no deal’ Brexit, because access to an initiative aimed at protecting patients from fake drugs could be lost. 12 February 2019
article
A long running dispute between two Dutch companies over ownership of methods for the processing of teff, a grain cultivated in Ethiopia, has been settled in the Court of The Hague. 11 February 2019
Americas
The University of California will soon be granted a patent related to the gene-editing technology CRISPR, according to a notice of allowance by the US Patent and Trademark Office. 11 February 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday dismissed an appeal by Massachusetts-based biotech Momenta Pharmaceuticals in a case involving a rheumatoid arthritis drug. 8 February 2019
Biotechnology
In a victory for Mayo Collaborative Services, a US Court has ruled that four claims in a patent, of which Athena Diagnostics is the exclusive licensee, are invalid. 7 February 2019
Medtech
The EU General Court today upheld the decision to invalidate a trademark owned by Swemac Innovation, a Swedish medical devices company. 7 February 2019
Americas
A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial. 6 February 2019
Americas
UK headquartered GSK has made another move in the oncology space, signing a potential €3.7 billion immunotherapy deal with Germany-based Merck KGaA. 6 February 2019
Americas
Rivals of British pharmaceutical company Indivior will soon be able to sell generic versions of opioid addiction treatment Suboxone film following a ruling of the US Court of Appeals for the Federal Circuit. 5 February 2019
Big Pharma
The Philippines Food and Drug Administration has issued a closure notice for a company allegedly responsible for producing counterfeit rabies vaccines. 4 February 2019